Jamieson Shannon, Hyde Philip, Card Patrick, Deehan David, Kirby John, Tyson-Capper Alison
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
School of Engineering, Newcastle University, Newcastle upon Tyne, United Kingdom.
Front Bioeng Biotechnol. 2025 Aug 5;13:1507248. doi: 10.3389/fbioe.2025.1507248. eCollection 2025.
The aim of this study was to assess potential pro-inflammatory responses induced in a human monocyte cell line by poly-ether-ether-ketone (PEEK) particles. Investigations also focussed on the role of toll-like receptor 4 (TLR4) and reactive oxygen species (ROS) in immune responses to PEEK.
PEEK particles were generated using a four-station multi-directional pin-on-plate wear simulator and used to treat THP-1 macrophages for 24 h at dosages of 0.5-50 μm per cell. THP-1 cell supernatant was used for protein secretion analysis using ELISA and gene expression investigations using RT-qPCR. TLR4 inhibition was also achieved using CLI-095 by treating cells prior to PEEK exposure. ROS production was investigated following PEEK treatment. IL-1β secretion was investigated by treating PEEK-exposed cells to 5 mM ATP for 1 h in order to assess the role of the inflammasome.
PEEK particles were not immediately cytotoxic to THP-1 macrophages and induced a significant increase in gene expression and protein secretion of IL-8, CCL2, CCL3, and CCL4 at the highest dose (p < 0.0001). This increase in pro-inflammatory genes and proteins was not inhibited following blockade of TLR4. ROS production was significantly upregulated in the PEEK-treated cells and IL-1β secretion was also significantly increased following the addition of ATP to PEEK-exposed THP-1 cells.
PEEK particles are capable of inducing a pro-inflammatory phenotype in a human macrophage cell line which is not a result of TLR4 activation. PEEK particles do act in a PAMP-like manner and are able to induce ROS production as well as initiate inflammasome activation.
本研究旨在评估聚醚醚酮(PEEK)颗粒在人单核细胞系中诱导的潜在促炎反应。研究还聚焦于Toll样受体4(TLR4)和活性氧(ROS)在对PEEK免疫反应中的作用。
使用四工位多向销盘磨损模拟器生成PEEK颗粒,并以每细胞0.5 - 50μm的剂量用于处理THP - 1巨噬细胞24小时。THP - 1细胞上清液用于通过酶联免疫吸附测定(ELISA)进行蛋白质分泌分析以及通过逆转录定量聚合酶链反应(RT - qPCR)进行基因表达研究。在PEEK暴露前通过用CLI - 095处理细胞来实现TLR4抑制。在PEEK处理后研究ROS产生。通过将暴露于PEEK的细胞用5mM三磷酸腺苷(ATP)处理1小时来研究白细胞介素 - 1β(IL - 1β)分泌,以评估炎性小体的作用。
PEEK颗粒对THP - 1巨噬细胞无即时细胞毒性,并且在最高剂量下诱导白细胞介素 - 8(IL - 8)、趋化因子CCL2、CCL3和CCL4的基因表达和蛋白质分泌显著增加(p < 0.0001)。在阻断TLR4后,促炎基因和蛋白质的这种增加未受到抑制。在PEEK处理的细胞中ROS产生显著上调,并且在向暴露于PEEK的THP - 1细胞中添加ATP后,IL - 1β分泌也显著增加。
PEEK颗粒能够在人巨噬细胞系中诱导促炎表型,这不是TLR4激活的结果。PEEK颗粒确实以类似病原体相关分子模式(PAMP)的方式起作用,并且能够诱导ROS产生以及启动炎性小体激活。